Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | CL Batlevi, S De Frank, C Stewart, PA Hamlin, MJ Matasar, JF Gerecitano, AJ Moskowitz, AM Hamilton, AD Zelenetz, P Drullinsky, DJ Straus, A Kumar, CH Moskowitz, J Dicostanzo, D Callan, D Tsui, J Rademaker, H Schöder, A Ni, A Younes | ||||||||||||
Title | Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma. | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/214/AbstView_214_229221.html | ||||||||||||
Abstract Text | J Clin Oncol 36, 2018 (suppl; abstr 7520) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|